My ePortfolio Register   

Immunotherapy of cancer: recent progress and future challenges

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.01.15
Views: 2442
Rating:

Prof Rolf Kiessling, Karolinska Institutet, Stockholm, Sweden

Prof Kiessling speaks to ecancer at the 2nd EurocanPlatform Translational Research Course about the relatively recent impact immunotherapy has been making on clinical practise.

He covers the approval of the first tumour vaccine, modified T-cells as well as checkpoint antibodies. He also explains current obstacles and the field’s next steps.

Learn more about the EurocanPlatform project here

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence